Aurobindo Pharma has announced the establishment of TheraNym, a dedicated contract manufacturing organisation specialising in biologics. This new entity aims to strengthen Aurobindo's footprint in the biologics manufacturing space. MSD, a global pharmaceutical company, is the anchor customer for TheraNym, indicating a significant partnership. The move reflects Aurobindo's strategic focus on expanding its capabilities in the biologics sector, which is a growing area within the Indian pharmaceutical industry. TheraNym will cater to the increasing demand for biologics contract manufacturing services, supporting both domestic and international clients. MSD is the anchor customer for the new contract manufacturing organisation. The update was published on 3 Jun 2026, 7:10 pm.